NEFL and Huntington disease: We then looked at the relationships between these imaging metrics and biofluid markers of neuronal damage and genetic–pathological burden, namely, NfL (sampled from both blood plasma and CSF) and CSF concentrations of mHTT, the pathogenic agent in HD.